Listed Company Search: Stock Symbol Search: Member Search:
 
 
 
Listed Companies Company Profiles
Listed Companies List
ALAPIS HOLDING INDUSTRIAL AND COMMERCIAL SOCIETE ANONYME OF PHARMACEUTICAL AND CHEMICAL PRODUCTS
General Information | News Feed | Events Calendar | Trade Aknowledgements | Annual Reports | Dividends | Stock Info | 30 Days Closing Prices
General Information
The company is under suspension from: 02-APR-12
Market Information
Category: UNDER SUSPENSION
Sector - Subsector: Health Care - Pharmaceuticals
Ticker Symbol of OASIS: ALAPIS
[30 Days Closing Prices]
Index Participation:
Contact Person: Leda Basta
Investor Relations Officer: Leda Basta
Listed Co Info
Activity: Alapis Group is activated in the Health sector and especially on research and development, production, distribution, sale and marketing of human pharma and parapharmaceutical products.
Foundation Year: 1981
Listing Date: 05/04/1999
Board of Directors : KAIMAKIS DIMITRIOS (PRESIDENT/NON EXECUTIVE MEMBER), ROSIADIS PATROKLOS (VICE PRESIDENT/CEO/EXECUTIVE MEMBER), TSAPAKIDIS ALEXANDROS (NON EXECUTIVE MEMBER), LAZARIDOU V NIKOLETTA (INDEPENDENT NON EXECUTIVE MEMBER), ARAVOSITAS S DIMITRIOS (INDEPENDENT NON EXECUTIVE MEMBER)
Personnel: Company - 300
Group - 532
Address: AFTOKRATOROS NIKOLAOU 2
Postal Code:176 71
ATHINA
Telephone: (213)-0175000/-1
Telefax: (210)-9238460
Web: http://www.alapis.eu
Email:  
IPOS: Special report of the BoD of ALAPIS S.A. provided for in paragraphs 4.1.4.1.1 and 4.1.4.1.2 of the regulation of the Athens Exchange.

Special report of the BoD of ALAPIS A.E.B.E. provided for in paragraphs 4.1.4.1.1 and 4.1.4.1.2 of the regulation of the Athens Exchange.

Report of the board of directors to the Extraordinary General Meeting of shareholders of ALAPIS S.A. dated 04.04.2011 in relation to the abrogation of the existing shareholder's pre-emption rights in the context of thw issuance of convertible bond loans, according to article 13 par. 10 of the codified law 2190/1920.